Search details
1.
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis.
Blood
; 141(20): 2508-2519, 2023 05 18.
Article
in English
| MEDLINE | ID: mdl-36800567
2.
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib.
Haematologica
; 2024 May 30.
Article
in English
| MEDLINE | ID: mdl-38813708
3.
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors.
Blood
; 137(15): 2103-2113, 2021 04 15.
Article
in English
| MEDLINE | ID: mdl-33270827
4.
The possible role of mutated endothelial cells in myeloproliferative neoplasms.
Haematologica
; 106(11): 2813-2823, 2021 Nov 01.
Article
in English
| MEDLINE | ID: mdl-34320782
5.
Knowledge prior to belief: Is extended better than enacted?
Behav Brain Sci
; 44: e152, 2021 11 19.
Article
in English
| MEDLINE | ID: mdl-34796796
6.
The meaning of Freedom after Covid-19.
Hist Philos Life Sci
; 43(1): 3, 2021 Jan 08.
Article
in English
| MEDLINE | ID: mdl-33417016
7.
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Hematol Oncol
; 38(5): 754-762, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32950042
8.
The e13a2 BCR-ABL transcript negatively affects sustained deep molecular response and the achievement of treatment-free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.
Cancer
; 125(10): 1674-1682, 2019 05 15.
Article
in English
| MEDLINE | ID: mdl-30707758
9.
Prognostic role of baseline 18 F-FDG PET/CT parameters in MALT lymphoma.
Hematol Oncol
; 37(1): 39-46, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30299563
10.
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis.
Am J Hematol
; 2024 May 20.
Article
in English
| MEDLINE | ID: mdl-38769689
11.
Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients.
Hematol Oncol
; 35(4): 828-834, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-27255829
12.
Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
Am J Hematol
; 91(5): 507-17, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26822317
13.
Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia.
Acta Haematol
; 135(1): 39-42, 2016.
Article
in English
| MEDLINE | ID: mdl-26376174
14.
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study.
Blood
; 132(5): 547-550, 2018 08 02.
Article
in English
| MEDLINE | ID: mdl-29898955
15.
Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French-Italian Experience of 134 Patients.
Cancers (Basel)
; 16(7)2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38610955
16.
Nutritional Strategies To Improve VRE Control.
Transplant Cell Ther
; 30(5): 548.e1-548.e4, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38460728
17.
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan.
Clin Lymphoma Myeloma Leuk
; 24(5): 323-331, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38369436
18.
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Transplant Cell Ther
; 30(6): 580.e1-580.e14, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38582286
19.
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study.
Leukemia
; 38(5): 1107-1114, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38459167
20.
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.
Cancer Discov
; 14(5): 737-751, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38230747